Ablynx, a Belgian biotechnology firm, has agreed to a €20 million deal with Merck to develop immunotherapies that can bolster the human body's potential to combat cancer cells, the Financial Times reported.
Breaking News
- FTX Founder Sam Bankman-Fried Could Get Over 100 Years in Prison After Cryptocurrency Fraud Case
- Taylor Swift Reaches Her Billionaire' Era,' Joining Elon Musk and Jeff Bezos on the List of World's Wealthiest People
- Biden Administration to Provide $1.5 Billion Loan to Reopen Michigan Nuclear Power Plant, a First in the US
The following bids, mergers, acquisitions and disposals were reported on Monday including Forbes, Axel Springer, MidCap Financial LLC, Goldman Sachs and others.
Subscribe to VCpost newsletter
Most Popular
- Former CEO Shoots Himself to Commit Suicide After Receiving $25 Million Record-Breaking Fine for Fraud at Steinhoff
- Xi Jinping Warns Dutch PM That 'No Force' Can Stop China's Technological Advancement Amid Export Restrictions
- Major AI Companies Unite to Create the World's First Artificial Superintelligence Alliance Worth $7.6 Billion
- Disney Investor Nelson Peltz Criticizes the Company’s 'Woke' Strategy, Questioning 'Black Panther' and 'The Marvels' Films
- Social Security Benefits to Increase for Some Seniors After Addressing Overpayment Issues
- Citigroup to Complete Sweeping Overhaul This Week After Laying Off 5,000 Employees
- Disney, Florida Gov. Ron DeSantis' Allies Settle Lawsuit Over Disney World Special District, Ending Feud Over 'Don't Say Gay' Law
- North Korea Refuses Peace Talk With Japan Unless They Confront Their 'Brutal' History; Business Relations at Risk